GE Healthcare
Serena Bright Industry’s 1st Contrast-Enhanced Guided Biopsy Solution Now Available in the US
Serena Bright is the industry’s first contrast-enhanced guided biopsy solution and will help empower clinicians and patients in their fight against breast cancer.
GE Healthcare
GE Healthcare Receives FDA Clearance for Vivid Ultra Edition
Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High-quality data acquisition and operator skill are key elements to achieve accurate and complete exams.
GE Healthcare
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury
Under the four-year agreement, GE Healthcare will commercialize Osprey’s DyeVert portfolio which reduces the amount of contrast that reaches the kidney (40% average reduction) with no compromise in image quality.
GE Healthcare
GE Healthcare Receives FDA Clearance of the Industry’s First Contrast-Enhanced Mammography Solution for Biopsy
The clearance comes at a time when women’s health clinics worldwide begin to reopen and are managing new protocols to help reduce staff and patient exposure to COVID-19.
